Topical steroid therapy as an alternative to circumcision for phimosis in boys younger than 3 years

James M Elmore1, Linda A Baker, Warren T Snodgrass

  • 1Department of Urology, Children's Medical Center and The University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.

The Journal of Urology
|September 28, 2002
PubMed

Insights

Topical steroid cream effectively treated phimosis in infants and young children, offering a non-surgical alternative to circumcision. This treatment resolved foreskin retraction issues in most boys, with no reported side effects.

Area of Science:

  • Pediatric Urology
  • Dermatology
  • Pharmacology

Background:

  • Phimosis, the inability to retract the foreskin, is common in infants and young children.
  • Topical steroids are an established treatment for older boys with secondary phimosis.
  • Circumcision is a common but invasive treatment for phimosis.

Purpose of the Study:

  • To evaluate the effectiveness of topical steroids as a non-surgical treatment for phimosis in infants and young children.
  • To determine if topical steroid therapy is a viable alternative to circumcision in this age group.

Main Methods:

  • A study included 27 boys aged 1-31 months with phimosis.
  • Patients applied 0.05% betamethasone cream twice daily for one month.
  • Indications for potential circumcision included genitourinary anomalies, urinary tract infections, or balanoposthitis.

Main Results:

  • 74% of boys achieved fully retractable foreskins after one month of betamethasone treatment.
  • An additional 18% showed partial improvement, with full retraction occurring in the second month.
  • No adverse side effects were observed during the treatment period.

Conclusions:

  • Topical steroid therapy, specifically betamethasone, is effective in resolving phimosis in boys under three years old.
  • This treatment offers a safe and effective alternative to circumcision for phimosis across all age groups and indications.
  • Topical steroids represent a significant advancement in non-invasive phimosis management for pediatric patients.
Abstract